The role of the NMDA receptor in alcohol relapse: a pharmacological mapping study using the alcohol deprivation effect Valentina Vengeliene a, * , Daniel Bachteler a , Wojciech Danysz b , Rainer Spanagel a a Department of Psychopharmacology, Central Institute of Mental Health (CIMH), J5, 68159 Mannheim, Germany b Merz Pharmaceuticals GmbH, Frankfurt am Main, Germany Received 24 September 2004; received in revised form 22 December 2004; accepted 6 January 2005 Abstract Modulators of glutamate receptors especially of the N-methyl-D-aspartate receptors (NMDARs) have recently been suggested as putative pharmacotherapeutic agents in the treatment of alcohol relapse. However, at present it is not clear, which binding and modulatory sites of the NMDAR are involved in relapse behavior. We, therefore, performed a pharmacological mapping study in long-term alcohol drinking rats using the alcohol deprivation effect (ADE) as a model for relapse behavior. In a comprehensive fashion, we studied doseeresponse curves, employing the following selective pharmacological agents: the NMDAR competitive antagonist CGP37849, the glycine binding site antagonist L-701.324, the NR2B subunit selective antagonist ifenprodil, which acts at the polyamine binding site, the NMDAR channel blocker neramexane, and ethanol, which acts as a functional antagonist at the NMDAR. Our data show that the animals’ alcohol consumption inversely correlates with the dose of ethanol administered intraperitoneally. This indicates that under the present experimental conditions alcohol intake during an ADE is an entirely pharmacologically driven behavior that is not under the control of other factors such as taste or novelty of alcohol re-exposure. The effects of the administration of the aforementioned compounds were comparable to those of ethanol, suggesting a similar pharmacological impact on relapse behavior. Repeated administration of both competitive and uncompetitive NMDAR antagonist dose-dependently suppressed alcohol consumption during ADE. In addition, ifenprodil and L-701.324 dose-dependently reduced the expression of an ADE as well. In summary, the results suggest that an inhibition of NMDAR function in general, rather than a particular interference with a specific binding site of this receptor, is sufficient for the reduction of relapse behavior. Ó 2005 Elsevier Ltd. All rights reserved. Keywords: NMDA; CGP37849; Neramexane; L-701.324; Ifenprodil; Alcohol deprivation effect (ADE); Relapse Glutamatergic systems are targets for the actions of alcohol via its antagonism of the N-methyl-D-aspartate receptor (NMDAR) and other mechanisms. Following chronic alcohol intake, adaptations within the glutama- tergic systems appear to contribute to alcohol depen- dence. In particular, the up-regulation of different subunits of the NMDAR (Dodd et al., 2000; Henninger et al., 2003; Nagy, 2004a) may cause hyperexcitability of the central nervous system during withdrawal or condi- tioned withdrawal and further possibly represent one mechanism involved in the induction of relapse behavior (Tsai and Coyle, 1998; Spanagel and Bienkowski, 2002; Krystal et al., 2003). In order to study alcohol relapse-like behavior in rats, a new model of long-term alcohol consumption with repeated deprivation phases has recently been developed Abbreviations: NMDA, N-methyl-D-aspartate; ADE, alcohol deprivation effect. * Corresponding author. Tel.: C49 621 17036261; fax: C49 621 17036255. E-mail address: vengeli@zi-mannheim.de (V. Vengeliene). 0028-3908/$ - see front matter Ó 2005 Elsevier Ltd. All rights reserved. doi:10.1016/j.neuropharm.2005.01.002 Neuropharmacology 48 (2005) 822e829 www.elsevier.com/locate/neuropharm